Evidence map›Paper›PMID 28686582›Full record

ArticleNature protocols2017

Measurement of drug-target engagement in live cells by two-photon fluorescence anisotropy imaging.

Claudio Vinegoni, Paolo Fumene Feruglio, Christian Brand, Sungon Lee, Antoinette E Nibbs, Shawn Stapleton, Sunil Shah, Ignacy Gryczynski, Thomas Reiner, Ralph Mazitschek and 1 more

Abstract read
In one paragraph

Article in Nature protocols, 2017. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 12 papers.

0numbers the graph read from it
0cells of the map it votes in
12citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

12 citing papers in PubMed.

  1. Regulation of RNA-binding proteins by small biomolecules.Nature reviews. Molecular cell biology · 2026
    Review
  2. Target Engagement Assays in Early Drug Discovery.Journal of medicinal chemistry · 2025
    Review
  3. Article
  4. Article
  5. Article
  6. Article
  7. Review
  8. Article
  9. Article
  10. Article
  11. Review
  12. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

11 authors.

Claudio VinegoniCenter for System Biology, Massachusetts General Hospital and Harvard Medical School, Boston, Massachusetts, USA.
Paolo Fumene FeruglioCenter for System Biology, Massachusetts General Hospital and Harvard Medical School, Boston, Massachusetts, USA.
Christian BrandDepartment of Radiology, Memorial Sloan Kettering Cancer Center, New York, New York, USA.
Sungon LeeCenter for System Biology, Massachusetts General Hospital and Harvard Medical School, Boston, Massachusetts, USA.
Antoinette E NibbsCenter for System Biology, Massachusetts General Hospital and Harvard Medical School, Boston, Massachusetts, USA.
Shawn StapletonCenter for System Biology, Massachusetts General Hospital and Harvard Medical School, Boston, Massachusetts, USA.
Sunil ShahInstitute for Molecular Medicine, University of North Texas Health Science Center, Fort Worth, Texas, USA.
Ignacy GryczynskiInstitute for Molecular Medicine, University of North Texas Health Science Center, Fort Worth, Texas, USA.
Thomas ReinerDepartment of Radiology, Memorial Sloan Kettering Cancer Center, New York, New York, USA.
Ralph MazitschekCenter for System Biology, Massachusetts General Hospital and Harvard Medical School, Boston, Massachusetts, USA.
Ralph WeisslederCenter for System Biology, Massachusetts General Hospital and Harvard Medical School, Boston, Massachusetts, USA.

Funding

X-RAY CRYSTALLOGRAPHYP30CA008748 · NCI · SLOAN-KETTERING INSTITUTE FOR CANCER RES · PI Hongbiao Carl Lekaye · 1985 to 2026
$347.4M
StatisticsP50CA086355 · NCI · MASSACHUSETTS GENERAL HOSPITAL · PI WEISSLEDER, MD, PHD, RALPH · 2000 to 2015
$27.8M
TRANSLATIONAL PHARMACOLOGY COREP50GM107618 · NIGMS · HARVARD MEDICAL SCHOOL · PI GOLAN, DAVID E. · 2014 to 2018
$10.8M
Novel Clickdyes for Biomedical SensingR01EB010011 · NIBIB · MASSACHUSETTS GENERAL HOSPITAL · PI WEISSLEDER, MD, PHD, RALPH · 2010 to 2017
$3.1M
Imaging tumor associated macrophage (TAM) functionR01CA206890 · NCI · MASSACHUSETTS GENERAL HOSPITAL · PI PITTET, MIKAEL, WEISSLEDER, MD, PHD, RALPH · 2017 to 2021
$1.9M
Single Cell Imaging of the HeartR01HL122208 · NHLBI · MASSACHUSETTS GENERAL HOSPITAL · PI WEISSLEDER, MD, PHD, RALPH · 2014 to 2017
$1.7M
NCI NIH HHS P30 CA008748NCI NIH HHS P50 CA086355NCI NIH HHS R01 CA206890NHLBI NIH HHS R01 HL122208NIBIB NIH HHS R01 EB010011NIGMS NIH HHS P50 GM107618
6 · The paper itself

Abstract

The ability to directly image and quantify drug-target engagement and drug distribution with subcellular resolution in live cells and whole organisms is a prerequisite to establishing accurate models of the kinetics and dynamics of drug action. Such methods would thus have far-reaching applications in drug development and molecular pharmacology. We recently presented one such technique based on fluorescence anisotropy, a spectroscopic method based on polarization light analysis and capable of measuring the binding interaction between molecules. Our technique allows the direct characterization of target engagement of fluorescently labeled drugs, using fluorophores with a fluorescence lifetime larger than the rotational correlation of the bound complex. Here we describe an optimized protocol for simultaneous dual-channel two-photon fluorescence anisotropy microscopy acquisition to perform drug-target measurements. We also provide the necessary software to implement stream processing to visualize images and to calculate quantitative parameters. The assembly and characterization part of the protocol can be implemented in 1 d. Sample preparation, characterization and imaging of drug binding can be completed in 2 d. Although currently adapted to an Olympus FV1000MPE microscope, the protocol can be extended to other commercial or custom-built microscopes.

Indexed as

Cytological TechniquesFluorescence PolarizationImage Processing, Computer-AssistedOptical ImagingPharmaceutical PreparationsPharmacologyPharmaceutical Preparations

Identifiers

PMID28686582
PMCPMC5928516

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.